About Pharmerica Corporation
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Stores
- Sub-Industry: Health Care Distributors
- Exchange: NYSE
- Symbol: PMC
- CUSIP: 71714F10
- Previous Close: $26.75
- 50 Day Moving Average: $25.49
- 200 Day Moving Average: $25.35
- 52-Week Range: $19.20 - $28.72
- Trailing P/E Ratio: 23.06
- Foreward P/E Ratio: 11.61
- P/E Growth: 3.11
- Market Cap: $778.76M
- Outstanding Shares: 30,781,000
- Beta: 1.1
- Net Margins: 1.64%
- Return on Equity: 10.40%
- Return on Assets: 4.68%
Companies Related to Pharmerica Corporation:
- Debt-to-Equity Ratio: 0.71%
- Current Ratio: 3.10%
- Quick Ratio: 2.25%
What is Pharmerica Corporation's stock symbol?
Pharmerica Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "PMC."
Where is Pharmerica Corporation's stock going? Where will Pharmerica Corporation's stock price be in 2017?
5 brokerages have issued twelve-month price objectives for Pharmerica Corporation's shares. Their forecasts range from $22.00 to $34.00. On average, they anticipate Pharmerica Corporation's stock price to reach $30.00 in the next twelve months.
When will Pharmerica Corporation announce their earnings?
Pharmerica Corporation is scheduled to release their next quarterly earnings announcement on Friday, February, 24th 2017.
Who owns Pharmerica Corporation stock?
Pharmerica Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (8.44%), FMR LLC (7.44%), State Street Corp (2.46%), Discovery Group I LLC (1.69%), Loomis Sayles & Co. L P (1.57%) and Systematic Financial Management LP (1.45%). Company insiders that own Pharmerica Corporation stock include Berard Tomassetti, Gregory S Weishar, Mark Lindemoen, Robert A Mckay and Thomas A Caneris.
Who sold Pharmerica Corporation stock? Who is selling Pharmerica Corporation stock?
Pharmerica Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Systematic Financial Management LP, Putnam Investments LLC, Thrivent Financial for Lutherans, Allianz Asset Management AG, Dimensional Fund Advisors LP, AQR Capital Management LLC and Century Capital Management LLC.
Who bought Pharmerica Corporation stock? Who is buying Pharmerica Corporation stock?
Pharmerica Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Discovery Group I LLC, Guggenheim Capital LLC, State Street Corp, Russell Investments Group Ltd., A.R.T. Advisors LLC, Oxford Asset Management, Cornercap Investment Counsel Inc. and Tudor Investment Corp Et Al.
How do I buy Pharmerica Corporation stock?
Shares of Pharmerica Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Pharmerica Corporation stock cost?
One share of Pharmerica Corporation stock can currently be purchased for approximately $25.30.